Система Orphus

China develops convalescent plasma therapy for COVID-19 patients

14.02.2020, 18:27 7912
China has developed convalescent plasma to treat patients who are infected with the novel coronavirus (COVID-19), according to the China National Biotec Group.
 
The company said they have collected plasma from some recovered patients to prepare therapeutic products including convalescent plasma and immune globulin, Xinhua reports.
 
After strict blood biosafety tests, virus inactivation and antiviral activity tests, they have successfully developed convalescent plasma for clinical treatment and have used it to treat critically ill patients.
 
The company has set up a team to use special equipment to collect plasma from recovered patients in Wuhan since Jan. 20.
 
Three critically ill patients in a hospital in the Jiangxia District of Wuhan received convalescent plasma treatment on Feb. 8. Currently, more than 10 critically ill patients have received the treatment, according to the company.
 
According to clinical results, 12 to 24 hours after the patients received the treatment, they have shown improved clinical symptoms, with main inflammatory indexes decreased significantly and some key indexes such as blood oxygen saturation improving comprehensively.
 
 
 This information may not be reproduced without reference to Kazakhstan Today. Copyright of materials of News Agency Kazakhstan Today.

When citing our content a hyperlink to this Kazakhstan Today website is obligatory.

Comments

relevant news